FDA Drug Application (022523) for PANCREAZE by JANSSEN PHARMS

Back to FDA Applications sponsored by JANSSEN PHARMS

Application Number022523
Product Number001
FormCAPSULE, DELAYED RELEASE;ORAL
Dosage17,500USP/ UNITS;4,200USP/ UNITS;10,000USP/ UNITS
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NamePANCREAZE
Active IngredientPANCRELIPASE (AMYLASE;LIPASE;PROTEASE)



Back to FDA Applications sponsored by JANSSEN PHARMS

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.